Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation. [electronic resource] by
- Rinaldi, D A
- Burris, H A
- Dorr, F A
- Woodworth, J R
- Kuhn, J G
- Eckardt, J R
- Rodriguez, G
- Corso, S W
- Fields, S M
- Langley, C
Producer: 19951215
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 13
Availability: No items available.
|
|
|
8.
|
A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. [electronic resource] by
- Rodriguez, G I
- Kuhn, J G
- Weiss, G R
- Hilsenbeck, S G
- Eckardt, J R
- Thurman, A
- Rinaldi, D A
- Hodges, S
- Von Hoff, D D
- Rowinsky, E K
Producer: 19980316
In:
Blood vol. 91
Availability: No items available.
|
|
|
9.
|
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies. [electronic resource] by
- Shaffer, D W
- Smith, L S
- Burris, H A
- Clark, G M
- Eckardt, J R
- Fields, S M
- Weiss, G R
- Rinaldi, D A
- Bowen, K J
- Kuhn, J G
Producer: 19940124
In:
Cancer research vol. 53
Availability: No items available.
|
|
|
10.
|
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies. [electronic resource] by
- Hammond, L A
- Eckardt, J R
- Baker, S D
- Eckhardt, S G
- Dugan, M
- Forral, K
- Reidenberg, P
- Statkevich, P
- Weiss, G R
- Rinaldi, D A
- Von Hoff, D D
- Rowinsky, E K
Producer: 20000106
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
|
11.
|
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation. [electronic resource] by
- Rinaldi, D A
- Kuhn, J G
- Burris, H A
- Dorr, F A
- Rodriguez, G
- Eckhardt, S G
- Jones, S
- Woodworth, J R
- Baker, S
- Langley, C
- Mascorro, D
- Abrahams, T
- Von Hoff, D D
Producer: 19991112
In:
Cancer chemotherapy and pharmacology vol. 44
Availability: No items available.
|
|
|
12.
|
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. [electronic resource] by
- Rothenberg, M L
- Kuhn, J G
- Schaaf, L J
- Rodriguez, G I
- Eckhardt, S G
- Villalona-Calero, M A
- Rinaldi, D A
- Hammond, L A
- Hodges, S
- Sharma, A
- Elfring, G L
- Petit, R G
- Locker, P K
- Miller, L L
- von Hoff, D D
Producer: 20020716
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 12
Availability: No items available.
|
|
|
13.
|
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. [electronic resource] by
- Rothenberg, M L
- Sharma, A
- Weiss, G R
- Villalona-Calero, M A
- Eckardt, J R
- Aylesworth, C
- Kraynak, M A
- Rinaldi, D A
- Rodriguez, G I
- Burris, H A
- Eckhardt, S G
- Stephens, C D
- Forral, K
- Nicol, S J
- Von Hoff, D D
Producer: 19981103
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 9
Availability: No items available.
|
|
|
14.
|
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. [electronic resource] by
- Rothenberg, M L
- Eckardt, J R
- Kuhn, J G
- Burris, H A
- Nelson, J
- Hilsenbeck, S G
- Rodriguez, G I
- Thurman, A M
- Smith, L S
- Eckhardt, S G
- Weiss, G R
- Elfring, G L
- Rinaldi, D A
- Schaaf, L J
- Von Hoff, D D
Producer: 19960725
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|